The Journal of Bone and Joint Surgery (American) 83:1891-1901 (2001)
© 2001 The Journal of Bone and Joint Surgery, Inc.
Instructional Course Lecture |
Antimicrobial Resistance: Guidelines for the Practicing Orthopaedic Surgeon
Douglas R. Osmon, MD, MPH
An Instructional Course Lecture, American Academy of Orthopaedic Surgeons
Douglas R. Osmon, MD, MPH
Division of Infectious Diseases, Department of Internal Medicine, Mayo
Clinic and Mayo Foundation, 200 First Street S.W., Rochester, MN 55905.
The author did not receive grants or outside funding in support
of his research or preparation of this manuscript. He did not receive
payments or other benefits or a commitment or agreement to provide
such benefits from a commercial entity. No commercial entity paid
or directed, or agreed to pay or direct, any benefits to any research
fund, foundation, educational institution, or other charitable or
nonprofit organization with which the author is affiliated or associated.
Printed with permission of the American Academy of Orthopaedic Surgeons.
This article, as well as other lectures presented at the Academys
Annual Meeting, will be available in March 2002 in Instructional
Course Lectures, Volume 51. The complete volume can be
ordered online at www.aaos.org, or by calling 800-626-6726 (8 a.m.-5
p.m., Central time).
 |
Introduction
|
|---|
Antimicrobial resistance among pathogens, such as Staphylococcus
aureus, coagulase-negative staphylococci, enterococci,
and aerobic gram-negative bacilli, is pervasive in the community
and hospital setting. Every practicing orthopaedist faces on a daily
basis the increasing problem of antimicrobial resistance in the
effort to prevent or treat nosocomial infections. Recognizing the scope
of the problem; understanding the mechanisms of antimicrobial resistance
as well as the epidemiology, prevention, and treatment of infections
due to resistant organisms; and knowing the proposed solutions to
these problems will optimize the orthopaedic surgeons ability
to manage multidrug-resistant nosocomial pathogens.
 |
Scope and Mechanisms of Antimicrobial Resistance
|
|---|
In 1990, the National Foundation for Infectious Diseases stated
that the estimated cost of nosocomial infections due to antimicrobial-resistant
pathogens in the United States was as high as $4 billion annually
and that antimicrobial resistance and emerging infections were the
most important problems in the prevention and control of infectious
diseases1,2. In 1995, in New York
City alone, . . . [Full Text of this Article]

CiteULike Connotea Del.icio.us Technorati What's this?
|